Overactive Bladder - Results from #2100

Effect of renal or hepatic impairment on the pharmacokinetics of mirabegron - Abstract December 13, 2012

Urological problems in Parkinson's disease: Clinical aspects - Abstract December 13, 2012

Long-term safety and efficacy of two different antimuscarinics, imidafenacin and solifenacin, for treatment of overactive bladder: A prospective randomized controlled study - Abstract December 11, 2012

Latest treatment for lower urinary tract dysfunction: Therapeutic agents and mechanism of action - Abstract December 11, 2012

Comparison of the effects of electrical stimulation and posterior tibial nerve stimulation in the treatment of overactive bladder syndrome - Abstract December 11, 2012

Urge perception index: A quantitative measure of bladder hyper-sensitivity in analysis of a bladder diary with a self-reported grading of urinary perception - Abstract December 10, 2012

Increased risk of large postvoid residual urine and lower long-term success rate in frail elderly after intravesical onabotulinumtoxin A injection for refractory idiopathic detrusor overactivity - Abstract December 10, 2012

Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: Results from a randomised European-Australian phase 3 trial - Abstract December 7, 2012

Five years follow-up study and failures analysis of botulinum toxin repeated injections to treat neurogenic detrusor overactivity - Abstract December 6, 2012

Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder - Abstract December 6, 2012

Cost-effectiveness analysis of anti-muscarinic agents for the treatment of overactive bladder - Abstract December 6, 2012

Clinical findings associated with bladder trabeculations in women - Abstract December 4, 2012

Urinary neurotrophic factors in healthy individuals and patients with overactive bladder - Abstract December 4, 2012

Lower urinary tract symptoms in patients with Niigata Minamata disease: A case-control study 50 years after methyl mercury pollution - Abstract December 3, 2012

Unconventional treatment procedures of the bladder in paraplegia and myelomeningocele - Abstract December 1, 2012

Persistent genital arousal disorder: Characterization, etiology, and management - Abstract November 30, 2012

Vesicoureteral reflux in overactive bladder: Medical resolution through botulin toxin injection - Abstract November 28, 2012

Sacral nerve stimulation for urinary dysfunction: The first year of the Scottish national service - Abstract November 21, 2012

Detrusor overactivity in diabetic and non-diabetic patients: Is there a difference? - Abstract November 20, 2012

Overactive bladder syndrome - management and treatment options - Abstract November 19, 2012

Page 106 of 125